( en | de | ru )

 

Disambiguation of "Bhatt, Deepak L."

Author of the publication

copydeleteadd this publication to your clipboard
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations

, , , , , , , , , , , and . (2024)
DOI: 10.1001/jamacardio.2023.5605

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Lavinia Bhatt

Alpana Bhatt

Deepak Bararia

Deepak Ajwani

Deepak Jain

 

Other publications of authors with the same name

Interpreting observational studies -- look before you leap., and . Journal of clinical epidemiology, 59 (8): 763-4 (August 2006)4211<m:linebreak></m:linebreak>PUBM: Print-Electronic; DEP: 20060515; JID: 8801383; 0 (Antilipemic Agents); CON: J Clin Epidemiol. 2006 Aug;59(8):819-28. PMID: 16828675; 2005/12/06 received; 2005/12/18 accepted; 2006/05/15 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tipus d&#039;estudis.On the use of propensity scores in case of rare exposure., , , , and . BMC medical research methodology, 16 (1): 38 (January 2016)Propensity score; IPTW; Online.Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020, , , , and . 330 (1): 80 (2023)Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI)., , , , , , , and . Circulation, 137 (2): 206-209 (January 2018)Comparacions múltiples; Early stopping; Exemples.An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials., , , , , , , and . npj Digit. Medicine, (2023)Predicting radiocephalic arteriovenous fistula success with machine learning., , , , , , , , and . npj Digit. Medicine, (2022)Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events., , , , , , , , , and 17 other author(s). The New England journal of medicine, 354 (16): 1706-17 (April 2006)Comparacions múltiples; Anàlisi de subgrups; CV; Exemple<br/><br/>Comentari a Lagakos, S. W. (2006). The challenge of subgroup analyses--reporting without distorting. <i>The New England Journal of Medicine</i>, <i>354</i>(16), 1667–9.Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations, , , , , , , , , and 2 other author(s). (2024)Adaptive Designs for Clinical Trials., and . The New England journal of medicine, 375 (1): 65-74 (July 2016)Disseny; Dissenys adaptatius; RCT; Introductori.Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome, , , , , , , , and . 142 (16): 1579--1590 (2020)